Challenges and Solutions for University Technology Commercialization (Part 2)

In Part 1 of this series, I touched on some of the unique considerations for advancing early-stage innovation beyond the academic setting. For this article, I’d like to dig deeper into the topic of university...

CardioWise Named Rising Star at the UCSF Health Awards

The University of California San Francisco (UCSF) Health Awards named CardioWise, Inc. as a Rising Star in the Clinical Diagnostic Tool category. The awards highlight the health tech industry, showcasing the best new...

Inside the OTT at Emory University with Associate Vice President of Research and Executive Director Todd Sherer, PhD

Please describe your background/career path that led you to your current role. I received my Doctorate in Toxicology and Molecular Biology from Washington State University and have spent the majority of my career in...

CardioWise, Inc. Named a Finalist in the Rising Star Clinical Diagnostics Tool or Platform Category by UCSF Health Hub

CardioWise™ is commercializing patented, Cardiac Computed Tomography (CT) machine learning analysis software, SQuEEZ™, which produces a quantified image model of human heart function. Fayetteville, AR - The University...

Tesseract Structural Innovations Partners with Cymat in APMA Electric Vehicle Project Arrow

Mississauga, Ontario – Cymat Technologies Ltd. (TSXV: CYM) (the "Company" or "Cymat") is pleased to announce that, in collaboration with design partner Tesseract Structural Innovations Inc. (“Tesseract”), Cymat has...

Dr. Brett King Joins BiologicsMD as Senior Scientific Advisor and Member of the Scientific Advisory Board

Leading expert in alopecia, Dr. Brett King brings deep academic insight, broad preclinical and clinical expertise and drug development experience to help BiologicsMD advance its innovative hair and bone therapies New...

VIC Fellows Spotlight: Danielle France, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovations from global sources. We are pleased to highlight the...

Dr. Davies-Cutting Brings Industry Leading Technical Expertise to Nob Hill Therapeutics

Albuquerque. NM, Nob Hill Therapeutics announced today the appointment of Craig Davies-Cutting, PhD, as Vice President of Research and Development. Dr. Davies-Cutting will contribute his extensive respiratory product...

Individual Investor Access to VC Stage Investments

In my last article, I discussed why individual investors should include privately held, innovation-driven companies in a diversified and balanced investment strategy [Seven Reasons Venture Capital-Stage Companies Should...

Filtravate Awarded National Science Foundation SBIR Phase I Grant

LAS CRUCES, NM - Filtravate, an ultrafiltration membrane company, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF) for...


VIC Tech Continues to Grow Its Medical Advisory Board
Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Inside CTTC at Vanderbilt University with Assistant Director, Physical Sciences Ashok Choudhury
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity
Cellia Science Formed to Develop and Commercialization Point-of-Care Hematology Analyzers
VIC Fellows Spotlight: Alexandra Antonioli, MD, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission